Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS
Cancer Medicine · 2026
DOI: 10.1002/cam4.71343 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cancer Medicine, 2026. Verfasst von Matthias Saar und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Pediatric Urology, University Medical Center RWTH Aachen, Aachen, Germany. Hauptthemen laut MEDLINE: Quality of Life, Prostatectomy, Prostatic Neoplasms, Castration-Resistant, Pyrazoles. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer AG, Bayer.
Abstract (Originalsprache)
Background
Darolutamide plus androgen‐deprivation therapy (ADT) improved metastasis‐free survival (MFS) by 2 years and reduced the risk of death by 31% in nonmetastatic castration‐resistant prostate cancer (nmCRPC) in ARAMIS. Prior local therapy may influence the efficacy of subsequent systemic therapy. This post hoc analysis of ARAMIS evaluated the effect of prior local therapy on the efficacy and health‐related quality of life (HRQoL) of darolutamide.
Methods
Patients with nmCRPC were randomized to darolutamide ( n = 955) or placebo ( n = 554) while continuing ADT. MFS, overall survival (OS), time to prostate‐specific antigen (PSA) progression, and HRQoL deterioration‐free survival (DetFS) were estimated for patients with and without local therapy and by treatment using Kaplan–Meier methods.
Results
Darolutamide increased MFS versus placebo in patients with (HR, 0.36; 95% CI, 0.26–0.48) and without (HR, 0.46; 95% CI, 0.36–0.59) local therapy. Median OS was 48.6 months for placebo without local therapy and not reached in either the darolutamide group or placebo group with local therapy. Darolutamide 3‐year OS rates were 86.9% (95% CI, 83.0–90.8) and 79.0% (95% CI, 66.2–78.1) in patients with and without local therapy, respectively. Darolutamide showed evidence of improved OS versus placebo in patients with prior local therapy (HR, 0.80; 95% CI, 0.50–1.30) and a greater effect in those without local therapy (HR, 0.67; 95% CI, 0.50–0.90). Darolutamide delayed time to PSA progression and HRQoL deterioration regardless of local therapy.
Conclusions
Darolutamide versus placebo improved MFS, OS, time to PSA progression, and HRQoL DetFS independent of prior local therapy, consistent with the overall ARAMIS population. Trial Registration: ClinicalTrials.gov registration: NCT02200614
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology and Pediatric Urology, University Medical Center RWTH Aachen, Aachen, Germany.
- Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
- Carolina Urologic Research Center, Myrtle Beach, South Carolina, USA.
- Massachusetts General Hospital, Boston, Massachusetts, USA.
- University of Gothenburg, Gothenburg, Sweden.
- Ivanovo Regional Oncology Dispensary, Ivanovo, Russia.
ORCID-Profile: Matthias Saar
Förderung
- Bayer AG
- Bayer
Zitieren
APA
Saar, M., Fizazi, K., Shore, N. D., Smith, M., Damber, J. E., Semenov, A., Ribal, M. J., Birtle, A., Rigaud, J., Wallis, C. J. D., Grimm, M. O., Halabi, S., Armstrong, A. J., Mohamed, A. F., Adorjan, P., Srinivasan, S., Verholen, F., Morgans, A. K., & Siemens, D. R. (2026). Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS. Cancer Medicine. https://doi.org/10.1002/cam4.71343
Vancouver
Saar M, Fizazi K, Shore ND, Smith M, Damber JE, Semenov A, et al. Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS. Cancer Medicine. 2026. doi:10.1002/cam4.71343
BibTeX
@article{Saar2026,
author = {Saar, Matthias and Fizazi, Karim and Shore, Neal D and Smith, Matthew and Damber, Jan-Erik and Semenov, Andrey and Ribal, Maria J and Birtle, Alison and Rigaud, Jérôme and Wallis, Christopher J D and Grimm, Marc-Oliver and Halabi, Susan and Armstrong, Andrew J and Mohamed, Ateesha F and Adorjan, Patrick and Srinivasan, Shankar and Verholen, Frank and Morgans, Alicia K and Siemens, D Robert},
title = {Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71343}
}
EUVIMED